'Fingerprints' help find genes involved in differentiation

Nov 14, 2007

A database that includes the molecular profiles of the major components of the blood system – including the stem cells and the cells differentiated from them – enabled researchers at Baylor College of Medicine (BCM) in Houston to identify at least two genes involved in the differentiation process for two different kinds of blood cells.

In a report that appears in the journal Cell Stem Cell today, Dr. Margaret A. Goodell, professor of pediatrics and director of BCM’s STem Cells and Regeneration Center (STaR), and her colleagues described how they used their database to determine what was unique to each blood cell and what was common to all the cell types.

Understanding differentiation and what signals cause the early or progenitor cells to become the more specialized tissues that make multicellular organisms – such as mammals – possible is of vital concern to scientists and particularly stem cell biologists.

In this case, the scientists identified between 100 and 400 genes uniquely expressed in each cell type and termed these “lineage fingerprints,” because they mark the different cells that arise from the various stem cells.

“With unique genes, some will be responsible for generating those cell types,” said Goodell. She and her colleagues caused two of the genes (Zfp105 from the natural killer or NK cell lineage, and Ets2 from the monocyte (white blood cells with a singe nucleus that surround and ingest foreign materials) lineage to overexpress or make more than usual amounts of protein.

“They ended up driving differentiation,” said Goodell. That means that genes encouraged progenitor or early forms of the cells to become the mature or final blood cells that carry out specific tasks in the blood system.

“We are hoping that if we screen more of these genes that we can identify others that cause differentiation,” she said.

In the future, she said, scientists might consider ways to use the genes to help generate the differentiated cells in the laboratory as a particular form of treatment or developing drugs to block the action of the genes. Overproduction of certain blood or immune system cells can lead to cancer or autoimmune disease.

The three-year study involved considerable teamwork, said Goodell, with individuals in the lab taking responsibility for studies involving the different populations of blood cells.


Source: Baylor College of Medicine

Explore further: Radiologist recommendations for chest CT have high clinical yield

add to favorites email to friend print save as pdf

Related Stories

NIST suggests new purity test for biotech products

Dec 03, 2014

To avoid contaminating their experiments, biomedical researchers want to know that the scientific products they buy are pure. But how pure does something need to be to really be pure? Using a new test, scientists ...

Colorful nano-guides to the liver

Dec 03, 2014

Jena scientists have been successful in producing highly specific nanoparticles. Depending on the bound dye the particles are guided to the liver or to the kidney and deliver their payload of active ingredients ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.